Abstract
Background Chronic obstructive pulmonary disease (COPD) accounts for 10% of emergency hospital admissions in the United Kingdom annually. Nearly 33% of patients are re-admitted within 28 days of discharge. We evaluated the effectiveness of implementing standardised packages of care called ‘care bundles’ on COPD re-admission, emergency department (ED) attendance, mortality, costs and process of care.
Methods Mixed-methods controlled before-and-after study with nested case studies. 31 acute hospitals in England and Wales which introduced COPD care bundles (implementation sites) or provided usual care (comparator sites) were recruited and provided monthly aggregate data. 14 sites provided additional individual patient data. Participants were adults admitted with an acute exacerbation of COPD.
Results There was no evidence that care bundles reduced 28-day COPD re-admission rates: OR=1·02 (95% CI:0·83, 1·26). However, the rate of ED attendance was reduced in implementation sites over and above that in comparator sites (implementation: IRR=0·63 (95% CI:0·56,0·71); comparator: IRR=1·12 (95% CI:1·02,1·24); group-time interaction p<0·001). At implementation sites, delivery of all bundle elements was higher but was only achieved in 2.2% (admissions bundle) and 7.6% (discharge bundle) of cases. There was no evidence of cost effectiveness. Staff viewed bundles positively, believing they help standardise practice and facilitate communication between clinicians. However, they lacked skills in change management leading to inconsistent implementation.
Discussion COPD care bundles were not effectively implemented in this study. They were associated with a reduced number of subsequent ED attendances, but not with change in re-admissions, mortality or reduced costs. This is unsurprising given the low level of bundle uptake in implementation sites and it remains to be determined if COPD care bundles affect patient care and outcomes when they are effectively implemented.
Methods Mixed-methods controlled before-and-after study with nested case studies. 31 acute hospitals in England and Wales which introduced COPD care bundles (implementation sites) or provided usual care (comparator sites) were recruited and provided monthly aggregate data. 14 sites provided additional individual patient data. Participants were adults admitted with an acute exacerbation of COPD.
Results There was no evidence that care bundles reduced 28-day COPD re-admission rates: OR=1·02 (95% CI:0·83, 1·26). However, the rate of ED attendance was reduced in implementation sites over and above that in comparator sites (implementation: IRR=0·63 (95% CI:0·56,0·71); comparator: IRR=1·12 (95% CI:1·02,1·24); group-time interaction p<0·001). At implementation sites, delivery of all bundle elements was higher but was only achieved in 2.2% (admissions bundle) and 7.6% (discharge bundle) of cases. There was no evidence of cost effectiveness. Staff viewed bundles positively, believing they help standardise practice and facilitate communication between clinicians. However, they lacked skills in change management leading to inconsistent implementation.
Discussion COPD care bundles were not effectively implemented in this study. They were associated with a reduced number of subsequent ED attendances, but not with change in re-admissions, mortality or reduced costs. This is unsurprising given the low level of bundle uptake in implementation sites and it remains to be determined if COPD care bundles affect patient care and outcomes when they are effectively implemented.
Original language | English |
---|---|
Article number | e000425 |
Number of pages | 10 |
Journal | BMJ Open Respiratory Research |
Volume | 6 |
Issue number | 1 |
DOIs | |
Publication status | Published - 30 May 2019 |
Research Groups and Themes
- BTC (Bristol Trials Centre)
- BRTC
- Centre for Surgical Research
Fingerprint
Dive into the research topics of 'Evaluation of 'care bundles' for patients with chronic obstructive pulmonary disease (COPD): a multisite study in the UK'. Together they form a unique fingerprint.Profiles
-
Professor William Hollingworth
- Bristol Medical School (PHS) - Professor of Health Economics
- Bristol Population Health Science Institute
- Cancer
Person: Academic , Member
-
Dr Stephanie J MacNeill
- Bristol Medical School (PHS) - Associate Professor in Medical Statistics
- Bristol Population Health Science Institute
Person: Academic , Member
-
Professor Chris Metcalfe
- Bristol Medical School (PHS) - Professor of Medical Statistics
- Bristol Population Health Science Institute
- Centre for Academic Mental Health
- Cancer
Person: Academic , Member